Levetiracetam 250mg Oral Solution from Japan
Sweetened oral solution at 250mg per dose for pediatric and geriatric epilepsy treatment. Falls under HTS 3004.90.92.41 for its prophylactic CNS anticonvulsant use in retail measured forms.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Stability testing for light-sensitive solutions mandatory
• Metered-dose packaging required for accuracy
• Avoid alcohol-containing formulations if prohibited for certain markets